Mangorx receives notice of acceptance for patent application in australia for respiratory illness and preventive care technology

Dallas, texas, june 06, 2024 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ed), hair growth, weight loss and hormone replacement therapies, is pleased to announce that it has received a notice of acceptance for australian patent application no. 2020235666, which is the national phase of international application no. pct/us2020/022903.
MGRX Ratings Summary
MGRX Quant Ranking